The CEO-Led Journey

Nobody cares as much about the future of a company as the people on the ground.

Jeff is the experienced CEO of Sequoia Biotech, a promising clinical-stage company. An industry veteran who has been through multiple company financings, he has learned how to create a competitive dynamic including the time and effort that goes into a well-run deal cycle.

Read More

A Tale of Two Deals

MotionHall provides the unexpected market insights dealmakers need to play their cards right.

Read More

Out-Licensing and Sell-Side M&A

• Protecting Downside
• Accelerated Outreach
• Beginning New Relationships
• Building Internal BD Muscle
• Building Platform Tech Strategy
• Investor Financing
• Niche Markets
• Novel Science
• The CBO-Led Deal
• The CEO-Led Journey
• Crowded Markets
• Elevating Your Banker
• Indication Prioritization
• Pipeline Prioritization

Reducing In-Licensing Risk

Leaf Bioscience Improves Company Upside While Reducing Risk in an In-Licensing Process

Read More

In-Licensing and Buy-Side M&A

• Reducing In-Licensing Risk
• Making a Transformational Buy